Displaying 13 - 24 of 29
Metabolism, Alcohol & Toxicity

Kickoff: The importance of early screening

Webcasts
View
Metabolism, Alcohol & Toxicity

Understanding burden of  MASLD: The Importance  on Quality of Life

Webcasts
View
Metabolism, Alcohol & Toxicity

Panel discussion

Webcasts
View
Metabolism, Alcohol & Toxicity

Welcome and introduction

Webcasts
View
Metabolism, Alcohol & Toxicity

Tools for early detection of metabolic risk in MAFLD

Webcasts
View
Metabolism, Alcohol & Toxicity

Insights from the SIRIUS project – a population-wide liver disease screening program in Slovakia

Webcasts
View
Metabolism, Alcohol & Toxicity

Early screening of metabolic risk – the pharmacists’ perspective

Webcasts
View
Metabolism, Alcohol & Toxicity

Summary and closing remarks

Webcasts
View
Metabolism, Alcohol & Toxicity

Sanofi: "Global Liver Health Forum 2023" (Complete Session)

Webcasts
View
Metabolism, Alcohol & Toxicity

Welcome and introduction

Webcasts
View
Metabolism, Alcohol & Toxicity

To what extent can HRQoL impact clinical outcomes in MAFLD?

Webcasts
View
Metabolism, Alcohol & Toxicity

Essential phospholipids in the liver health landscape – clinical evidence

Webcasts
View
Displaying 13 - 24 of 29